KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Other Gross PP&E Adjustments (2018 - 2025)

Twist Bioscience (TWST) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with $114.4 million as the latest value for Q2 2023.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 240.88% to $114.4 million in Q2 2023 year-over-year; TTM through Jun 2023 was $114.4 million, a 240.88% increase, with the full-year FY2022 number at $83.1 million, up 640.46% from a year prior.
  • Other Gross PP&E Adjustments was $114.4 million for Q2 2023 at Twist Bioscience, down from $117.2 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $117.2 million in Q1 2023 to a low of -$84.4 million in Q1 2022.
  • A 5-year average of $920875.0 and a median of -$31.7 million in 2020 define the central range for Other Gross PP&E Adjustments.
  • Biggest YoY gain for Other Gross PP&E Adjustments was 640.46% in 2022; the steepest drop was 172.21% in 2022.
  • Twist Bioscience's Other Gross PP&E Adjustments stood at -$37.2 million in 2019, then increased by 13.18% to -$32.3 million in 2020, then tumbled by 149.97% to -$80.8 million in 2021, then skyrocketed by 232.13% to $106.8 million in 2022, then rose by 7.14% to $114.4 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Other Gross PP&E Adjustments are $114.4 million (Q2 2023), $117.2 million (Q1 2023), and $106.8 million (Q4 2022).